USP 795 guidelines pertain to what type of compounding?

The USP 795 guidelines specifically address non-sterile compounding, which involves the preparation of medications that are not subjected to sterilization. This includes various forms of drugs, such as creams, ointments, and oral solutions, that must meet specific standards for quality and preparation to ensure safety and efficacy.

Non-sterile compounding is critical in pharmacy practice because it allows pharmacists to prepare medications that are tailored to individual patient needs, often when commercially available products do not suffice. The guidelines provide detailed procedures for formulation, quality control, and labeling to ensure that compounded medications are made safely and effectively.

In contrast, the other choices focus on specific aspects of compounding that either relate to sterile processes or specific practice settings. Sterile compounding, covered under USP 797, deals with preparations that must be free from microorganisms and applicable in environments where contamination can have significant health consequences. Inpatient and outpatient compounding refer to settings where these practices are performed, rather than the specific type of compounding, and do not define the guidelines' focus on non-sterile preparations. Understanding USP 795 is crucial for pharmacists involved in developing and dispensing non-sterile compounded medications.